Skip to content

Author

Xiangwei Wu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Integrative multi-omics profiling reveals DRG1 promotes hepatocellular carcinoma via c-Myc phosphorylation and facilitates lenvatinib resistance.

The findings identify DRG1 as a potential prognostic biomarker and therapeutic target in HCC and identify its underlying regulatory mechanisms as a potential strategy to improve lenvatinib response.

Peng Wang, Jun-Ying Xu, Hao Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.